Total Payments
$45,530
2023 Payments
$11,257
Companies
10
Transactions
23
Payment Breakdown by Category
Consulting$43,470 (95.5%)
Travel$1,534 (3.4%)
Food & Beverage$526.47 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $43,470 | 6 | 95.5% |
| Travel and Lodging | $1,534 | 4 | 3.4% |
| Food and Beverage | $526.47 | 13 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $22,108 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $11,800 | 1 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $11,170 | 3 | $0 (2023) |
| Alcon Laboratories Inc | $152.63 | 2 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $116.44 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $57.51 | 3 | $0 (2019) |
| Oyster Point Pharma, Inc. | $50.89 | 1 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $38.06 | 2 | $0 (2018) |
| ITI, Inc. | $18.31 | 1 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $17.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $11,257 | 6 | Regeneron Pharmaceuticals, Inc. ($11,170) |
| 2020 | $22,748 | 4 | GlaxoSmithKline, LLC. ($11,800) |
| 2019 | $11,197 | 7 | Horizon Therapeutics plc ($11,160) |
| 2018 | $231.72 | 5 | Aerie Pharmaceuticals, Inc. ($116.44) |
| 2017 | $96.14 | 1 | Alcon Laboratories Inc ($96.14) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/02/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $50.89 | General |
| Category: DRY EYE | ||||||
| 05/11/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VYZULTA, PROLENSA | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Ophthalmology | ||||||
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $6,111.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $4,636.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/10/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $421.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/18/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $11,800.00 | General |
| 01/17/2020 | Horizon Therapeutics plc | — | Consulting Fee | Cash or cash equivalent | $10,250.00 | General |
| 01/17/2020 | Horizon Therapeutics plc | — | Travel and Lodging | Cash or cash equivalent | $673.43 | General |
| 01/17/2020 | Horizon Therapeutics plc | — | Food and Beverage | Cash or cash equivalent | $24.96 | General |
| 10/18/2019 | Horizon Therapeutics plc | — | Consulting Fee | Cash or cash equivalent | $10,250.00 | General |
| 10/18/2019 | Horizon Therapeutics plc | — | Travel and Lodging | In-kind items and services | $510.24 | General |
| 10/18/2019 | Horizon Therapeutics plc | — | Travel and Lodging | In-kind items and services | $186.67 | General |
| 10/18/2019 | Horizon Therapeutics plc | — | Travel and Lodging | In-kind items and services | $163.19 | General |
| 10/18/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $49.90 | General |
| 06/05/2019 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2019 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2018 | Novartis Pharmaceuticals Corporation | AZOPT (Drug), SIMBRINZA, TRAVATAN Z | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $116.44 | General |
| Category: Ophthalmology | ||||||
| 06/05/2018 | Alcon Laboratories Inc | CyPass (Device) | Food and Beverage | In-kind items and services | $56.49 | General |
| Category: Ophthalmology | ||||||
| 05/28/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), PROLENSA, LOTEMAX GEL | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/11/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), PROLENSA, LOTEMAX GEL | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/09/2017 | Alcon Laboratories Inc | ACTIVEFOCUS (Device), AcrySof, ORA | Food and Beverage | In-kind items and services | $96.14 | General |
| Category: Ophthalmology | ||||||
About Dr. Jayne Weiss, MD
Dr. Jayne Weiss, MD is a Ophthalmology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548200090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayne Weiss, MD has received a total of $45,530 in payments from pharmaceutical and medical device companies, with $11,257 received in 2023. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($43,470).
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Cornea and External Diseases Specialist
- Location New Orleans, LA
- Active Since 06/06/2006
- Last Updated 05/20/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1548200090
Products in Payments
- EYLEA HD (Biological) $11,170
- Rhopressa (Drug) $116.44
- ACTIVEFOCUS (Device) $96.14
- CyPass (Device) $56.49
- TYRVAYA (Drug) $50.89
- VYZULTA (Drug) $38.06
- AZOPT (Drug) $20.73
- DUREZOL (Drug) $20.50
- CAPLYTA (Drug) $18.31
- XIPERE (Drug) $17.77
- TRAVATAN Z (Drug) $16.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New Orleans
Donald Mazzulla, Md, MD
Ophthalmology — Payments: $211,127
Ophthalmology $211,127
Pulin Shah, Md, MD
Ophthalmology — Payments: $201,632
Ophthalmology $201,632
Dr. Rebecca Metzinger, Md, MD
Ophthalmology — Payments: $63,634
Ophthalmology $63,634
Lena Al-Dujaili
Ophthalmology — Payments: $46,197
Ophthalmology $46,197
Ze Zhang, Md, MD
Ophthalmology — Payments: $39,081
Ophthalmology $39,081
Dr. Peter Kastl, Md, MD
Ophthalmology — Payments: $18,896
Ophthalmology $18,896